GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD), one of the most common liver diseases, is caused by the disruption of hepatic lipid homeostasis. It is associated with insulin resistance as seen in type 2 diabetes mellitus. Glucagon-like peptide-1 (GLP-1) is an incretin that increases insulin sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jinmi, Hong, Seok-Woo, Rhee, Eun-Jung, Lee, Won-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428412/
https://www.ncbi.nlm.nih.gov/pubmed/22950055
http://dx.doi.org/10.4093/dmj.2012.36.4.262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428412/
https://www.ncbi.nlm.nih.gov/pubmed/22950055
http://dx.doi.org/10.4093/dmj.2012.36.4.262

Ejemplares similares